Skip to main content
Premium Trial:

Request an Annual Quote

Sadashi Suzuki and Wendell Wierenga

Premium

Sadashi Suzuki has been hired as Affymetrix’ s general manager for Japan and will work out of the new Affymetrix Japan Tokyo office, which will open in January. Suzuki has 25 years experience in the pharmaceutical, healthcare, and life sciences industries at companies such as Kyowa Hakko Kogyo, Baxter International, and Alcon Laboratories.

Wendell Wierenga, CEO of Syrrx, has joined Ciphergen Biosystems’ board of directors. Wierenga joined Syrrx as CEO in September 2000, after working for Pfizer and Warner-Lambert.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.